Recent insider trading activity from Bergman Alan B., including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | 20/20 Biolabs, Inc. | $AIDX | Bergman Alan B. | Chief Financial Officer | A | Stock Option | 100000 | $0.00 | 100,000.0000 | 4,930,287 | 9999.99% | 2.03% |